Edition:
United States

Concordia International Corp (CXRX.OQ)

CXRX.OQ on NASDAQ Stock Exchange Global Select Market

0.50USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
49,927
52-wk High
$3.52
52-wk Low
$0.45

Select another date:

Tue, Nov 21 2017

Drug firm Concordia overcharged Britain's health service with 6,000 percent price rise

LONDON Drug company Concordia overcharged Britain's health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country's Competition and Markets Authority said on Tuesday.

UPDATE 1-Drug firm Concordia overcharged Britain's health service with 6,000 pct price rise

LONDON, Nov 21 Drug company Concordia overcharged Britain's health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country's Competition and Markets Authority said on Tuesday.

Britain says Canada's Concordia overcharging health service for thyroid drug

LONDON, Nov 21 Drug company Concordia overcharged Britain's health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country's Competition and Markets Authority said on Tuesday.

BRIEF-Concordia International ‍comments on UK CMA statement of objections related to Liothyronine

* ‍COMMENTS ON CMA STATEMENT OF OBJECTIONS RELATED TO LIOTHYRONINE; SAYS "DO NOT BELIEVE THAT COMPETITION LAW HAS BEEN INFRINGED​"

BRIEF-Concordia International Q3 ‍reported revenue $154.6 mln

* Concordia International announces third quarter 2017 results

BRIEF-Concordia International seeks to realign capital structure under CBCA

* Concordia International Corp. takes next step to realign its capital structure by commencing proceedings under the Canada Business Corporations Act

BRIEF-Concordia International - ‍decided to use a 30-day grace period to defer payment of about $26 million

* Concordia International - ‍decided to use a 30-day grace period to defer payment of about $26 million of interest due oct 16 on its $735 million unsecured notes​

BRIEF-Concordia International-‍ UK CMA investigating into co's international segment

* Concordia International-‍ UK CMA investigating issues related to UK pharmaceutical sector, co's international segment,certain products part of inquiry​

BRIEF-Concordia International says ‍UK Competition and Markets Authority investigating pharma sector​

* Says ‍UK competition and markets authority is investigating new issues in relation to UK pharmaceutical sector​

BRIEF-Concordia International Corp. Announces release date for deliver strategy

* Concordia International Corp. Announces release date for deliver strategy

Select another date: